Where Is the Tonsillar Lymph Node and Why Does It Swell?

The tonsillar lymph node, formally called the jugulodigastric lymph node, sits just below and behind the angle of the jaw, roughly where the posterior belly of the digastric muscle crosses the internal jugular vein. It is the primary node that collects lymph draining from the palatine tonsils, and it is frequently the first node to enlarge when the tonsils are fighting an infection or harboring disease. Because the palatine tonsils themselves are dense lymphoid organs packed with immune cells, the tonsillar lymph node works as part of an interconnected surveillance system guarding the entrance to the throat. Understanding this node means understanding the tonsils it serves, how they trap pathogens, and why swelling in that spot under your jaw can signal anything from a routine sore throat to something more serious.

Where It Sits and What It Drains

The jugulodigastric node belongs to the upper deep cervical chain, a group of nodes running alongside the internal jugular vein in the neck. It is the largest node in this chain and is sometimes palpable even in healthy people. Its job is to filter lymphatic fluid arriving from the palatine tonsils, the back of the tongue, and surrounding pharyngeal tissue. When you or your doctor feel a tender, marble-sized lump just below the angle of the jaw during a bout of tonsillitis, that is almost always this node doing its job.

The palatine tonsils themselves are not simple lumps of tissue. They are structured lymphoid organs embedded in the lateral walls of the oropharynx, each riddled with deep invaginations called crypts. These crypts dramatically increase the surface area exposed to whatever you swallow or inhale, and their lining is specialized for immune sampling. The crypt epithelium is not uniform: it contains patches of ordinary squamous epithelium interspersed with patches of sponge-like “reticulated” epithelium, where the basement membrane is disrupted and immune cells freely mingle with epithelial cells.¹ This architecture lets the tonsils sample antigens directly from the throat, process them, and send immune signals downstream to the tonsillar lymph node and beyond.

How the Tonsils Sample Pathogens

The tonsils owe much of their immune power to specialized cells embedded in the crypt epithelium called M cells. These cells actively grab particles, bacteria, and viral fragments from the throat surface and shuttle them through the epithelial layer to the immune cells waiting underneath. Research in animal models first identified tonsillar M cells by showing they could take up tracer proteins and transport them to lymphocytes nestled in pockets beneath the cell surface.² Later work confirmed that these M cells form pockets harboring lymphoid cells and are functionally competent at antigen uptake.³

Similar M cells have been found in human adenoid tissue (the pharyngeal tonsil), where they were shown to be structurally and functionally comparable to M cells in the gut’s Peyer’s patches.⁴ The takeaway is that the tonsils are not passive bystanders. They are active gateways that grab whatever passes through the throat, hand it off to immune cells, and generate responses that ripple outward through the lymphatic system, with the tonsillar lymph node as the first downstream checkpoint.

Bovine studies add an interesting detail: the reticular epithelium overlying tonsillar lymphoid follicles contains significantly more B cells, helper T cells, and antigen-presenting cells than the surrounding non-reticular epithelium, along with cells resembling the M cells found in other species.⁵ The concentration of immune cells right at the crypt surface reinforces how finely tuned this sampling system is.

Germinal Centers and Antibody Production

Once antigens are captured, the real action happens inside structures called germinal centers, which are clusters of rapidly dividing and mutating B cells found within the tonsil’s lymphoid follicles. Tonsillar germinal centers are distinctive. They have four recognizable compartments, including a dark zone where B cells proliferate intensely and light zones where those B cells are tested for how well their newly mutated antibodies bind the target antigen. Interestingly, this compartmental organization differs from what is seen in ordinary lymph nodes, where the boundaries between zones are less distinct and certain marker-expressing cell networks extend into areas where they would not be found in tonsils.⁶

Within these germinal centers, B cells progress through a detailed maturation sequence. They enter as naive cells, undergo rapid mutation of their antibody genes, get tested for binding quality, switch their antibody class (for instance, from IgM to IgA or IgG), and either die off if they fail or graduate as memory B cells ready to respond faster next time.⁷ T follicular helper cells orchestrate much of this process. These specialized T cells are essential for selecting the best B cell clones and helping antibodies mature.⁸ A specific subset of T follicular helper cells marked by CD25 appears to support the later stages of B cell maturation, helping produce memory cells and class-switched antibodies.⁹

The system also has built-in brakes. A recently described population of regulatory T cells that descend from helper T cells, known as induced T follicular regulatory cells, inhabit the germinal centers and can suppress overactive immune responses while still retaining the ability to assist B cells. A separate population of natural T follicular regulatory cells acts as stronger suppressors and tends to sit outside the germinal centers in the follicular mantle zone.¹⁰ This balance between help and suppression is critical: too little regulation and the immune response can go haywire, as happens in some autoimmune conditions linked to the tonsils.

The Vascular Highways That Feed the System

Immune cells do not simply wander into the tonsils at random. The tonsillar blood supply includes specialized blood vessels called high endothelial venules, which have an unusually thick endothelial lining that acts as a docking station for circulating lymphocytes. These venules are the entry points through which lymphocytes in the blood home to the tonsillar tissue, responding to chemical signals that tell them an immune response is needed.¹¹ After lymphocytes do their work in the tonsil, they exit through the lymphatic drainage that feeds into the tonsillar lymph node. A swollen tonsillar node, then, is not just a sign of infection at the tonsils. It is a sign that large numbers of immune cells are being activated and circulated through this network.

Why the Tonsillar Node Swells During Infections

The most common reason people notice a swollen tonsillar lymph node is bacterial or viral pharyngitis. The tonsils are constantly exposed to microbes, and their crypts harbor a complex resident microbiome of between 42 and 110 bacterial taxa, including a core of about 12 abundant genera present regardless of age or health status.¹² When pathogenic bacteria overwhelm this commensal community, or when a virus takes hold, the immune machinery in the tonsils ramps up, germinal centers expand, and the downstream tonsillar lymph node swells as it processes the flood of activated immune cells and antigens.

Some infections are stubbornly recurrent, and the reason has less to do with treatment failure and more to do with where the bacteria hide. Streptococcus pyogenes, the cause of strep throat, was found living inside pharyngeal epithelial cells in 93% of patients with active tonsillitis, and even in about a third of asymptomatic carriers, bacteria were detected inside tonsillar epithelial cells or macrophage-like cells.¹³ Staphylococcus aureus takes a similar strategy. In recurrent tonsillitis, nearly all tonsil-associated S. aureus strains were found residing inside tonsillar cells, with about 87% of isolates confirmed as invasive strains rather than surface colonizers. This intracellular location shields the bacteria from both antibiotics and the host immune system.¹⁴ These persistent intracellular reservoirs help explain why antibiotics sometimes fail to clear recurrent tonsillitis and why the tonsillar lymph node may stay enlarged between episodes.

Crypt depth also matters for complications. Deeper tonsillar crypts have been associated with a higher risk of peritonsillar abscess, a painful complication where pus collects in the tissue surrounding the tonsil. Male sex and a history of recurrent tonsillitis are additional risk factors.¹⁵ A peritonsillar abscess almost always causes dramatic swelling of the tonsillar lymph node and surrounding cervical nodes.

HPV, Tonsillar Crypts, and Cancer Risk

One of the more alarming reasons a tonsillar lymph node can enlarge is cancer originating in the tonsil itself, and human papillomavirus (HPV) plays a central role. HPV-related tonsillar carcinomas tend to arise specifically in the tonsillar crypts, the same deep folds that are so well-designed for immune sampling. HPV-16 integration into crypt cells appears to be an early event, leading to disrupted cell-cycle regulation and, eventually, poorly differentiated tumors that tend to grow inward.¹⁶ The crypt environment itself may facilitate this process, as research has found that myeloid immune cells are enriched in tonsillar crypts and may foster conditions that make HPV infection more likely to persist.¹⁷

The irony is striking: the same crypt architecture that makes tonsils effective immune sensors also makes them vulnerable to a virus that exploits that access. HPV-positive tonsillar cancers have been rising steeply in incidence in recent decades, particularly in younger adults, even as HPV-negative head and neck cancers linked to smoking have declined. A persistently enlarged, hard, painless tonsillar lymph node in an adult, especially on one side, is a clinical red flag that warrants investigation for possible malignancy.

How Tonsillar Cancers Spread Through Neck Nodes

When tonsillar squamous cell carcinoma does develop, it has characteristic patterns of lymph node spread that guide surgical decisions. The tonsillar lymph node itself (level II in surgical terminology) is the most common site of metastasis, but spread can extend further. In patients with clinically undetectable neck disease, about 18% were found to have hidden metastatic nodes on pathological examination, mainly in level II on the same side as the tumor.¹⁸

Spread to the opposite side of the neck is a more ominous finding. In one surgical series, the rate of hidden contralateral metastasis was about 29%, and advanced primary tumor stage, tumors close to the midline, and disease already involving multiple node levels on the same side were all significant predictors.¹⁹ Retropharyngeal node metastasis, found in about a quarter of cases in that same series, carried a significant survival disadvantage. A separate study found that fewer than 10% of patients who underwent elective dissection of the contralateral neck had positive findings, and the degree of tumor differentiation was associated with contralateral spread.²⁰ These patterns inform the extent of neck surgery recommended for each patient.

Imaging can help detect disease in the tonsillar region early. Ultrasound, for example, has been shown to be useful in differentiating tonsillar lymphoma from simple inflammation. Primary tonsillar lymphomas tend to present as spherical, enlarged tonsils with a uniformly low-echo internal pattern and loss of the normal striped architecture, with abnormal blood-flow signals inside.²¹

The Tonsil–Kidney Connection

One of the less intuitive consequences of tonsillar immune activity is its link to a kidney disease called IgA nephropathy. In this condition, abnormally produced IgA antibodies deposit in the kidney’s filtering units, causing inflammation and, over time, damage. Evidence increasingly points to the tonsils as a source of this problematic IgA. Germinal center B cells in tonsils from patients with IgA nephropathy have been found to aberrantly produce a signaling molecule called APRIL at elevated levels compared with tonsils from patients with ordinary tonsillitis. This overproduction was driven by repeated stimulation of a specific immune receptor (TLR9) and correlated with greater protein spillage into the urine.²²

Another piece of the puzzle involves a type of B cell not normally found in germinal centers. In IgA nephropathy patients, these cells (called B-1 cells) accumulate in tonsillar germinal centers and resist the normal programmed-death signals that would otherwise clear them out. Because they are likely producing the IgA1 subclass most implicated in kidney damage, their abnormal survival may directly contribute to disease.²³ This connection explains why tonsillectomy has been explored as a treatment for IgA nephropathy, particularly in Japan, where some patients with high tonsillar APRIL expression showed decreases in the abnormal IgA after surgery.²⁴ The broader idea that mucosal infections, especially tonsillitis, can generate the nephritogenic IgA that drives kidney damage has gained considerable support.²⁵

What Happens to Immunity After Tonsillectomy

Given how much immune activity the tonsils generate, a natural question is whether removing them carries lasting consequences. The evidence is mixed, and it depends on what you measure. In one study comparing children who had undergone tonsillectomy with a matched control group, serum levels of the antibody classes IgM, IgA, and IgG were all significantly lower in the tonsillectomy group, while T cell and natural killer cell populations showed no meaningful differences.²⁶ This suggests the tonsils contribute measurably to circulating antibody levels, but that cell-mediated immunity is largely unaffected.

A large population study using Danish health records found more concrete long-term associations. Tonsillectomy in childhood was associated with roughly a two- to three-fold increase in upper respiratory tract diseases over the following decades. There were also smaller but statistically significant increases across a wide range of infectious and allergic conditions, with an overall 17% increase in the relative risk of infectious diseases after adenotonsillectomy, corresponding to an absolute risk increase of about 2%.²⁷ These numbers do not mean tonsillectomy is always a bad idea. For children with severe obstructive sleep apnea or truly recurrent strep infections, the benefits often outweigh these statistical risks. But the data do suggest the tonsils are not immunologically disposable in the way they were once treated.

Partial tonsillectomy (tonsillotomy), which removes the bulk of the tonsil tissue while preserving the capsule and some outer tissue, has been explored as a way to reduce symptoms while sparing immune function. One study comparing long-term outcomes found that antibiotic-treated upper respiratory infections occurred at similar rates in both partial and full tonsillectomy groups.²⁸ This similarity may reflect that the immune functions most relevant to respiratory defense are shared with other mucosal lymphoid tissues. Animal studies support this: in mice, removing the nasal-associated lymphoid tissue (the rodent equivalent of tonsils and adenoids) did not prevent the development of influenza-specific antibodies in either blood or nasal secretions, suggesting redundancy in the mucosal immune network.²⁹

Tonsils Across Species

Humans are far from the only animals with tonsillar tissue. A survey of domestic and laboratory species found that up to six distinct tonsils can exist in domestic animals, including lingual, palatine, paraepiglottic, pharyngeal, tubal, and soft-palate varieties. Sheep and goats have all six. Dogs and cats lack the tubal tonsil and the tonsil of the soft palate. Pigs have no palatine tonsils at all, while rabbits have only palatine tonsils. Rats and pigeons lack true tonsils entirely.³⁰ This variation matters for veterinary medicine and for choosing appropriate animal models in immunological research. It also underscores how the throat-guarding immune structures have been shaped differently by evolutionary pressures depending on diet, habitat, and pathogen exposure.

Human palatine tonsil development begins early. The tonsils start forming around the 14th week of gestation, when immune precursor cells invade the tissue lining the tonsillar cavity. By about the 16th week, epithelial crypts begin growing into the underlying tissue and are infiltrated by T cells. Primary lymphoid follicles appear earlier in the tonsils than in any other secondary lymphoid organ, suggesting the tonsils are among the first immune outposts to become operational.³¹ By the time a child is born, the tonsillar immune infrastructure is already substantially in place, ready to begin sampling the microbial world with the first breath and first feeding.